Nanyang Biologics harnesses AI to unlock therapeutic potential in natural compounds
Nanyang Biologics harnesses AI to unlock therapeutic potential in natural compounds
4 PagesEquinix helped Nanyang Biologics by providing AI-ready, high-performance data centers that power the company’s Drug-Target Interaction Graph Neural Network (DTIGN) platform. This infrastructure supports complex, high-density AI workloads necessary to efficiently analyze billions of natural compounds, accelerating drug discovery by 68% while reducing R&D costs by 90%. Equinix’s global connectivity and scalable computing resources enable Nanyang Biologics to harness AI and biological data at scale, unlocking the therapeutic potential of plant-derived compounds and advancing biomedical innovation.
